Subxiphoid Thoracoscopic Surgery Is Safe and Feasible for the Treatment of Anterior Mediastinal Teratomas: A Multicentre Retrospective Study

This study analyzed 159 patients with mediastinal benign teratomas across five hospitals from 2014–2024, comparing subxiphoid thoracoscopic surgery with other surgical approaches. Among the 26 patients undergoing subxiphoid surgery, the median operative time was 80 minutes with 20mL of blood loss and 100 percent complete resection rates. The subxiphoid approach showed superior outcomes, including faster recovery, reduced costs, and lower morbidity compared to median sternotomy, lateral thoracotomy, lateral thoracoscopy, and robotic surgery. The authors concluded that this technique is a safe and feasible alternative for anterior mediastinal teratoma resection.